KYMR – kymera therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Kymera Therapeutics (NASDAQ:KYMR) had its "buy" rating reaffirmed by analysts at B. Riley.
Kymera Therapeutics (NASDAQ:KYMR) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Kymera Had a Big Week. This Secretive Hedge Fund Bought $172 Million of Its Stock. [Yahoo! Finance]
Kymera Therapeutics Announces Closing of Upsized $602 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Kymera gains Fast Track status for oral candidate KT-621 for eczema [Seeking Alpha]
Form 4 Kymera Therapeutics, For: Dec 17 Filed by: Mainolfi Nello
Form 4 Kymera Therapeutics, For: Dec 17 Filed by: Esposito Pamela
Form 144 Kymera Therapeutics, Filed by: Esposito Pamela
Form SCHEDULE 13D/A Kymera Therapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
Form 4 Kymera Therapeutics, For: Dec 10 Filed by: Booth Bruce
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.